Quantification of DNA methylation for carcinogenic risk estimation in patients with non-alcoholic steatohepatitis

Abstract

After a further prospective validation study using a larger cohort, carcinogenic risk estimation in liver biopsy specimens of patients with NASH may become clinically applicable using this HPLC-based system for quantification of DNA methylation.